PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device and diagnostics industries, included TrialBlazer in its annual Innovations Issue, which highlights the most interesting advancements in the industry across 13 categories.
Recognized as one of only 5 products in the Clinical Trials category, TrialBlazer is Spectrum’s proprietary pre-screening software solution designed to optimize the participant, site and sponsor experience and accelerate clinical trial enrollment while providing holistic performance data all the way down the funnel, from outreach to study completion.
As the premier, full-service partner with a synergistic approach to patient recruitment helping sponsors big and small accelerate enrollment in difficult to recruit studies, we’re always innovating in the clinical trial recruitment space for the betterment of all stakeholders.
In total, 56 innovations were selected by PM360’s editorial staff for inclusion in the issue out of hundreds of submissions, and we’re proud that our work in the clinical trial space is being recognized. See the full list of innovations here.
Special shoutout to our CrowdPharm colleagues for their inclusion in the Artificial Intelligence category!